SiteMinder x Cloudbeds
SiteMinder and Cloudbeds partner to create new distribution and revenue opportunities for hotels
June 11, 2024 06:00 ET | Cloudbeds
San Diego, CA, June 11, 2024 (GLOBE NEWSWIRE) -- SiteMinder, the name behind the only software platform that unlocks the full revenue potential of hotels, and Cloudbeds, the leading platform...
Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market
Global Premenstrual Syndrome (PMS) & Menstrual Health Supplements Market Report 2024-2033: Combined Nutritional Supplements Lead the Way in $37.23 Billion PMS and Menstrual Health Market by 2033
June 06, 2024 05:02 ET | Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market - A Global and Regional Analysis: Focus on Product, Indication, Formulation, Sales...
Cloudbeds + Cendyn
Cloudbeds and Cendyn partner to enhance hotel revenue and guest experience
May 14, 2024 09:06 ET | Cloudbeds
San Diego, CA, May 14, 2024 (GLOBE NEWSWIRE) -- Cloudbeds, the premier hospitality management software platform, and Cendyn, a global integrated hotel technology and services company, have today...
Breakdown of reasons given by women who canceled plans due to a gynecological condition.
National Poll Shows Women Are Missing Out on Vacations, Work, and Social Events Due to Gynecological Conditions
May 02, 2024 10:00 ET | LevLane
PHILADELPHIA, May 02, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, today released the findings of a women's health survey...
22157.jpg
Global PMS and Menstrual Health Supplements Market Analysis, 2024-2028 & 2033, by Product, Formulation, Consumer Group, Sales Channel, and Region
March 26, 2024 13:17 ET | Research and Markets
Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "PMS and Menstrual Health Supplements Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The PMS and menstrual...
BIO.png
BioAdaptives, Inc. Commences Development of a New Supplement for Women’s Health
October 05, 2023 08:00 ET | BioAdaptives, Inc.
PluriPain®-PMS is an Advanced Derivative of the Company’s Popular Supplement, PluriPain® LAS VEGAS, NV, Oct. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTC: BDPT), a...
IGC Pharma.png
IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.
March 20, 2023 08:45 ET | IGC Pharma, Inc.
POTOMAC, Md., March 20, 2023 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces it will begin operating under the new name IGC...
Global Premenstrual Syndrome Treatment Market
Outlook on the Premenstrual Syndrome Treatment Global Market to 2027: Increasing Prevalence of PMS and Premenstrual Dysphoric Disorder (PMDD) Across the World Drives Growth
February 23, 2023 11:03 ET | Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Premenstrual Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
IGC Logo.jpg
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022
February 14, 2023 19:41 ET | INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (dba IGC, Inc.) (NYSE American: IGC) (“IGC” or the “Company”) today reported its third fiscal...
IGC Logo.jpg
IGC Announces Updated Life Sciences Presentation
December 20, 2022 08:30 ET | INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”), today announces that a life sciences presentation has been filed with...